¥77,400
biological source
human
Quality Segment
recombinant
expressed in E. coli
assay
≥97% (SDS-PAGE and N-terminal analysis)
form
lyophilized powder
potency
0.1-15.0 ng/mL
mol wt
27 kDa
packaging
pkg of 50 μg
storage condition
avoid repeated freeze/thaw cycles
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... FGF5(2250)
Application
Biochem/physiol Actions
Physical form
Analysis Note
1 of 1
当該品目 | |||
|---|---|---|---|
| recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in E. coli |
| assay ≥97% (SDS-PAGE and N-terminal analysis) | assay ≥97% (SDS-PAGE) | assay ≥95% (SDS-PAGE) | assay ≥97% (SDS-PAGE) |
| biological source human | biological source human | biological source human | biological source human |
| technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) - |
| Quality Level 100 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| form lyophilized powder | form lyophilized powder | form lyophilized powder | form lyophilized powder |
保管分類
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
名称等を表示すべき危険物及び有害物
ishl_indicated
名称等を通知すべき危険物及び有害物
ishl_notified
F4537-50UG: + F4537-50UG-PW: + F4537-BULK: + F4537-VAR:
jan



